APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pathology AI Software

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pathology AI Software Market Analysis and Forecast 2026-2032

5 March 2026203 pages

Choose your research edition.

Industry ResearchPathology AI Software Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Pathology AI Software Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Pathology AI Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pathology AI Software Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Pathology AI Software Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Pathology AI Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pathology AI Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pathology AI Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pathology AI Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pathology AI Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pathology AI Software include PathAI, Proscia, Aiforia, Deep Bio, Hologic, Dipath, iDeepwise, LBP and F.Q pathtech, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pathology AI Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pathology AI Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Pathology AI Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pathology AI Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pathology AI Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pathology AI Software revenue, projected growth trends, production technology, application and end-user industry.

Pathology AI Software Segment by Company

PathAI

Proscia

Aiforia

Deep Bio

Hologic

Dipath

iDeepwise

LBP

F.Q pathtech

CellaVision

AIRA Matrix

Syntropy

Indica Labs

DoMore Diagnostics

Mindpeak

Evidium

Pathology AI Software Segment by Type

Cloud-Based

On-Premise

Pathology AI Software Segment by Application

Hospital

Diagnostic Centers

Laboratories & Research Institutes

Pathology AI Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pathology AI Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pathology AI Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pathology AI Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pathology AI Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pathology AI Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pathology AI Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pathology AI Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cloud-Based Major Player Table 3. On-Premise Major Player Table 4. Global Pathology AI Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Diagnostic Centers Major Player Table 7. Laboratories & Research Institutes Major Player Table 8. Pathology AI Software Industry Trends Table 9. Pathology AI Software Industry Drivers Table 10. Pathology AI Software Industry Opportunities and Challenges Table 11. Pathology AI Software Industry Restraints Table 12. Global Pathology AI Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Pathology AI Software Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Pathology AI Software Market Share by Region (2021-2026) Table 15. Global Pathology AI Software Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Pathology AI Software Market Share by Region (2027-2032) Table 17. Global Pathology AI Software Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Pathology AI Software Revenue Market Share by Players (2021-2026) Table 19. Global Pathology AI Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Pathology AI Software Key Players Headquarters & Area Served Table 21. Global Pathology AI Software Players, Product Type & Application Table 22. Global Pathology AI Software Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Pathology AI Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Pathology AI Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pathology AI Software Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Pathology AI Software Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Pathology AI Software Revenue Market Share by Type (2021-2026) Table 29. Global Pathology AI Software Revenue Market Share by Type (2027-2032) Table 30. Global Pathology AI Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pathology AI Software Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Pathology AI Software Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Pathology AI Software Revenue Market Share by Application (2021-2026) Table 34. Global Pathology AI Software Revenue Market Share by Application (2027-2032) Table 35. PathAI Company Information Table 36. PathAI Business Overview Table 37. PathAI Pathology AI Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. PathAI Pathology AI Software Product Portfolio Table 39. PathAI Recent Development Table 40. Proscia Company Information Table 41. Proscia Business Overview Table 42. Proscia Pathology AI Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Proscia Pathology AI Software Product Portfolio Table 44. Proscia Recent Development Table 45. Aiforia Company Information Table 46. Aiforia Business Overview Table 47. Aiforia Pathology AI Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Aiforia Pathology AI Software Product Portfolio Table 49. Aiforia Recent Development Table 50. Deep Bio Company Information Table 51. Deep Bio Business Overview Table 52. Deep Bio Pathology AI Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Deep Bio Pathology AI Software Product Portfolio Table 54. Deep Bio Recent Development Table 55. Hologic Company Information Table 56. Hologic Business Overview Table 57. Hologic Pathology AI Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Hologic Pathology AI Software Product Portfolio Table 59. Hologic Recent Development Table 60. Dipath Company Information Table 61. Dipath Business Overview Table 62. Dipath Pathology AI Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Dipath Pathology AI Software Product Portfolio Table 64. Dipath Recent Development Table 65. iDeepwise Company Information Table 66. iDeepwise Business Overview Table 67. iDeepwise Pathology AI Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. iDeepwise Pathology AI Software Product Portfolio Table 69. iDeepwise Recent Development Table 70. LBP Company Information Table 71. LBP Business Overview Table 72. LBP Pathology AI Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. LBP Pathology AI Software Product Portfolio Table 74. LBP Recent Development Table 75. F.Q pathtech Company Information Table 76. F.Q pathtech Business Overview Table 77. F.Q pathtech Pathology AI Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. F.Q pathtech Pathology AI Software Product Portfolio Table 79. F.Q pathtech Recent Development Table 80. CellaVision Company Information Table 81. CellaVision Business Overview Table 82. CellaVision Pathology AI Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. CellaVision Pathology AI Software Product Portfolio Table 84. CellaVision Recent Development Table 85. AIRA Matrix Company Information Table 86. AIRA Matrix Business Overview Table 87. AIRA Matrix Pathology AI Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. AIRA Matrix Pathology AI Software Product Portfolio Table 89. AIRA Matrix Recent Development Table 90. Syntropy Company Information Table 91. Syntropy Business Overview Table 92. Syntropy Pathology AI Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Syntropy Pathology AI Software Product Portfolio Table 94. Syntropy Recent Development Table 95. Indica Labs Company Information Table 96. Indica Labs Business Overview Table 97. Indica Labs Pathology AI Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Indica Labs Pathology AI Software Product Portfolio Table 99. Indica Labs Recent Development Table 100. DoMore Diagnostics Company Information Table 101. DoMore Diagnostics Business Overview Table 102. DoMore Diagnostics Pathology AI Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. DoMore Diagnostics Pathology AI Software Product Portfolio Table 104. DoMore Diagnostics Recent Development Table 105. Mindpeak Company Information Table 106. Mindpeak Business Overview Table 107. Mindpeak Pathology AI Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Mindpeak Pathology AI Software Product Portfolio Table 109. Mindpeak Recent Development Table 110. Evidium Company Information Table 111. Evidium Business Overview Table 112. Evidium Pathology AI Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Evidium Pathology AI Software Product Portfolio Table 114. Evidium Recent Development Table 115. North America Pathology AI Software Revenue by Type (2021-2026) & (US$ Million) Table 116. North America Pathology AI Software Revenue by Type (2027-2032) & (US$ Million) Table 117. North America Pathology AI Software Revenue by Application (2021-2026) & (US$ Million) Table 118. North America Pathology AI Software Revenue by Application (2027-2032) & (US$ Million) Table 119. North America Pathology AI Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America Pathology AI Software Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Pathology AI Software Revenue by Country (US$ Million) & (2027-2032) Table 122. Europe Pathology AI Software Revenue by Type (2021-2026) & (US$ Million) Table 123. Europe Pathology AI Software Revenue by Type (2027-2032) & (US$ Million) Table 124. Europe Pathology AI Software Revenue by Application (2021-2026) & (US$ Million) Table 125. Europe Pathology AI Software Revenue by Application (2027-2032) & (US$ Million) Table 126. Europe Pathology AI Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Europe Pathology AI Software Revenue by Country (2021-2026) & (US$ Million) Table 128. Europe Pathology AI Software Revenue by Country (US$ Million) & (2027-2032) Table 129. China Pathology AI Software Revenue by Type (2021-2026) & (US$ Million) Table 130. China Pathology AI Software Revenue by Type (2027-2032) & (US$ Million) Table 131. China Pathology AI Software Revenue by Application (2021-2026) & (US$ Million) Table 132. China Pathology AI Software Revenue by Application (2027-2032) & (US$ Million) Table 133. Asia Pathology AI Software Revenue by Type (2021-2026) & (US$ Million) Table 134. Asia Pathology AI Software Revenue by Type (2027-2032) & (US$ Million) Table 135. Asia Pathology AI Software Revenue by Application (2021-2026) & (US$ Million) Table 136. Asia Pathology AI Software Revenue by Application (2027-2032) & (US$ Million) Table 137. Asia Pathology AI Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Asia Pathology AI Software Revenue by Region (US$ Million) & (2021-2026) Table 139. Asia Pathology AI Software Revenue by Region (US$ Million) & (2027-2032) Table 140. SAMEA Pathology AI Software Revenue by Type (2021-2026) & (US$ Million) Table 141. SAMEA Pathology AI Software Revenue by Type (2027-2032) & (US$ Million) Table 142. SAMEA Pathology AI Software Revenue by Application (2021-2026) & (US$ Million) Table 143. SAMEA Pathology AI Software Revenue by Application (2027-2032) & (US$ Million) Table 144. SAMEA Pathology AI Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. SAMEA Pathology AI Software Revenue by Country (2021-2026) & (US$ Million) Table 146. SAMEA Pathology AI Software Revenue by Country (US$ Million) & (2027-2032) Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Pathology AI Software Image Figure 2. Global Pathology AI Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pathology AI Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cloud-Based Image Figure 5. On-Premise Image Figure 6. Global Pathology AI Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pathology AI Software Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Diagnostic Centers Image Figure 10. Laboratories & Research Institutes Image Figure 11. Global Pathology AI Software Market Size (US$ Million) & (2021-2032) Figure 12. Global Pathology AI Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pathology AI Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Pathology AI Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Pathology AI Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pathology AI Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Pathology AI Software Revenue Market Share by Type (2021-2032) Figure 19. Global Pathology AI Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Pathology AI Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Pathology AI Software Revenue Market Share by Application (2021-2032) Figure 22. North America Pathology AI Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Pathology AI Software Revenue Share by Type (2021-2032) Figure 24. North America Pathology AI Software Revenue Share by Application (2021-2032) Figure 25. North America Pathology AI Software Revenue Share by Country (2021-2032) Figure 26. United States Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Pathology AI Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Pathology AI Software Revenue Share by Type (2021-2032) Figure 31. Europe Pathology AI Software Revenue Share by Application (2021-2032) Figure 32. Europe Pathology AI Software Revenue Share by Country (2021-2032) Figure 33. Germany Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Pathology AI Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Pathology AI Software Revenue Share by Type (2021-2032) Figure 43. China Pathology AI Software Revenue Share by Application (2021-2032) Figure 44. Asia Pathology AI Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Pathology AI Software Revenue Share by Type (2021-2032) Figure 46. Asia Pathology AI Software Revenue Share by Application (2021-2032) Figure 47. Asia Pathology AI Software Revenue Share by Region (2021-2032) Figure 48. Japan Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Pathology AI Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Pathology AI Software Revenue Share by Type (2021-2032) Figure 56. SAMEA Pathology AI Software Revenue Share by Application (2021-2032) Figure 57. SAMEA Pathology AI Software Revenue Share by Country (2021-2032) Figure 58. Brazil Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Pathology AI Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-Based
  • On-Premise
Applications
  • Hospital
  • Diagnostic Centers
  • Laboratories & Research Institutes
Companies covered
  • PathAI
  • Proscia
  • Aiforia
  • Deep Bio
  • Hologic
  • Dipath
  • iDeepwise
  • LBP
  • F.Q pathtech
  • CellaVision
  • AIRA Matrix
  • Syntropy
  • Indica Labs
  • DoMore Diagnostics
  • Mindpeak
  • Evidium

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pathology AI Software Market by Type
  3. 1.2.1 Global Pathology AI Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cloud-Based
  5. 1.2.3 On-Premise
  6. 1.3 Pathology AI Software Market by Application
  7. 1.3.1 Global Pathology AI Software Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Diagnostic Centers
  10. 1.3.4 Laboratories & Research Institutes
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Pathology AI Software Market Dynamics
  1. 2.1 Pathology AI Software Industry Trends
  2. 2.2 Pathology AI Software Industry Drivers
  3. 2.3 Pathology AI Software Industry Opportunities and Challenges
  4. 2.4 Pathology AI Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pathology AI Software Market Perspective (2021-2032)
  2. 3.2 Global Pathology AI Software Growth Trends by Region
  3. 3.2.1 Global Pathology AI Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pathology AI Software Market Size by Region (2021-2026)
  5. 3.2.3 Global Pathology AI Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pathology AI Software Revenue by Players
  2. 4.1.1 Global Pathology AI Software Revenue by Players (2021-2026)
  3. 4.1.2 Global Pathology AI Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pathology AI Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pathology AI Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pathology AI Software Key Players Headquarters & Area Served
  7. 4.4 Global Pathology AI Software Players, Product Type & Application
  8. 4.5 Global Pathology AI Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pathology AI Software Market CR5 and HHI
  11. 4.6.3 2025 Pathology AI Software Tier 1, Tier 2, and Tier 3
5 Pathology AI Software Market Size by Type
  1. 5.1 Global Pathology AI Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pathology AI Software Revenue by Type (2021-2032)
  3. 5.3 Global Pathology AI Software Revenue Market Share by Type (2021-2032)
6 Pathology AI Software Market Size by Application
  1. 6.1 Global Pathology AI Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pathology AI Software Revenue by Application (2021-2032)
  3. 6.3 Global Pathology AI Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 PathAI
  2. 7.1.1 PathAI Company Information
  3. 7.1.2 PathAI Business Overview
  4. 7.1.3 PathAI Pathology AI Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 PathAI Pathology AI Software Product Portfolio
  6. 7.1.5 PathAI Recent Developments
  7. 7.2 Proscia
  8. 7.2.1 Proscia Company Information
  9. 7.2.2 Proscia Business Overview
  10. 7.2.3 Proscia Pathology AI Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Proscia Pathology AI Software Product Portfolio
  12. 7.2.5 Proscia Recent Developments
  13. 7.3 Aiforia
  14. 7.3.1 Aiforia Company Information
  15. 7.3.2 Aiforia Business Overview
  16. 7.3.3 Aiforia Pathology AI Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Aiforia Pathology AI Software Product Portfolio
  18. 7.3.5 Aiforia Recent Developments
  19. 7.4 Deep Bio
  20. 7.4.1 Deep Bio Company Information
  21. 7.4.2 Deep Bio Business Overview
  22. 7.4.3 Deep Bio Pathology AI Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Deep Bio Pathology AI Software Product Portfolio
  24. 7.4.5 Deep Bio Recent Developments
  25. 7.5 Hologic
  26. 7.5.1 Hologic Company Information
  27. 7.5.2 Hologic Business Overview
  28. 7.5.3 Hologic Pathology AI Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Hologic Pathology AI Software Product Portfolio
  30. 7.5.5 Hologic Recent Developments
  31. 7.6 Dipath
  32. 7.6.1 Dipath Company Information
  33. 7.6.2 Dipath Business Overview
  34. 7.6.3 Dipath Pathology AI Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Dipath Pathology AI Software Product Portfolio
  36. 7.6.5 Dipath Recent Developments
  37. 7.7 iDeepwise
  38. 7.7.1 iDeepwise Company Information
  39. 7.7.2 iDeepwise Business Overview
  40. 7.7.3 iDeepwise Pathology AI Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 iDeepwise Pathology AI Software Product Portfolio
  42. 7.7.5 iDeepwise Recent Developments
  43. 7.8 LBP
  44. 7.8.1 LBP Company Information
  45. 7.8.2 LBP Business Overview
  46. 7.8.3 LBP Pathology AI Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 LBP Pathology AI Software Product Portfolio
  48. 7.8.5 LBP Recent Developments
  49. 7.9 F.Q pathtech
  50. 7.9.1 F.Q pathtech Company Information
  51. 7.9.2 F.Q pathtech Business Overview
  52. 7.9.3 F.Q pathtech Pathology AI Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 F.Q pathtech Pathology AI Software Product Portfolio
  54. 7.9.5 F.Q pathtech Recent Developments
  55. 7.10 CellaVision
  56. 7.10.1 CellaVision Company Information
  57. 7.10.2 CellaVision Business Overview
  58. 7.10.3 CellaVision Pathology AI Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 CellaVision Pathology AI Software Product Portfolio
  60. 7.10.5 CellaVision Recent Developments
  61. 7.11 AIRA Matrix
  62. 7.11.1 AIRA Matrix Company Information
  63. 7.11.2 AIRA Matrix Business Overview
  64. 7.11.3 AIRA Matrix Pathology AI Software Revenue and Gross Margin (2021-2026)
  65. 7.11.4 AIRA Matrix Pathology AI Software Product Portfolio
  66. 7.11.5 AIRA Matrix Recent Developments
  67. 7.12 Syntropy
  68. 7.12.1 Syntropy Company Information
  69. 7.12.2 Syntropy Business Overview
  70. 7.12.3 Syntropy Pathology AI Software Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Syntropy Pathology AI Software Product Portfolio
  72. 7.12.5 Syntropy Recent Developments
  73. 7.13 Indica Labs
  74. 7.13.1 Indica Labs Company Information
  75. 7.13.2 Indica Labs Business Overview
  76. 7.13.3 Indica Labs Pathology AI Software Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Indica Labs Pathology AI Software Product Portfolio
  78. 7.13.5 Indica Labs Recent Developments
  79. 7.14 DoMore Diagnostics
  80. 7.14.1 DoMore Diagnostics Company Information
  81. 7.14.2 DoMore Diagnostics Business Overview
  82. 7.14.3 DoMore Diagnostics Pathology AI Software Revenue and Gross Margin (2021-2026)
  83. 7.14.4 DoMore Diagnostics Pathology AI Software Product Portfolio
  84. 7.14.5 DoMore Diagnostics Recent Developments
  85. 7.15 Mindpeak
  86. 7.15.1 Mindpeak Company Information
  87. 7.15.2 Mindpeak Business Overview
  88. 7.15.3 Mindpeak Pathology AI Software Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Mindpeak Pathology AI Software Product Portfolio
  90. 7.15.5 Mindpeak Recent Developments
  91. 7.16 Evidium
  92. 7.16.1 Evidium Company Information
  93. 7.16.2 Evidium Business Overview
  94. 7.16.3 Evidium Pathology AI Software Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Evidium Pathology AI Software Product Portfolio
  96. 7.16.5 Evidium Recent Developments
8 North America
  1. 8.1 North America Pathology AI Software Revenue (2021-2032)
  2. 8.2 North America Pathology AI Software Revenue by Type (2021-2032)
  3. 8.2.1 North America Pathology AI Software Revenue by Type (2021-2026)
  4. 8.2.2 North America Pathology AI Software Revenue by Type (2027-2032)
  5. 8.3 North America Pathology AI Software Revenue Share by Type (2021-2032)
  6. 8.4 North America Pathology AI Software Revenue by Application (2021-2032)
  7. 8.4.1 North America Pathology AI Software Revenue by Application (2021-2026)
  8. 8.4.2 North America Pathology AI Software Revenue by Application (2027-2032)
  9. 8.5 North America Pathology AI Software Revenue Share by Application (2021-2032)
  10. 8.6 North America Pathology AI Software Revenue by Country
  11. 8.6.1 North America Pathology AI Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pathology AI Software Revenue by Country (2021-2026)
  13. 8.6.3 North America Pathology AI Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Pathology AI Software Revenue (2021-2032)
  2. 9.2 Europe Pathology AI Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pathology AI Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pathology AI Software Revenue by Type (2027-2032)
  5. 9.3 Europe Pathology AI Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pathology AI Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pathology AI Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pathology AI Software Revenue by Application (2027-2032)
  9. 9.5 Europe Pathology AI Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pathology AI Software Revenue by Country
  11. 9.6.1 Europe Pathology AI Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pathology AI Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pathology AI Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Pathology AI Software Revenue (2021-2032)
  2. 10.2 China Pathology AI Software Revenue by Type (2021-2032)
  3. 10.2.1 China Pathology AI Software Revenue by Type (2021-2026)
  4. 10.2.2 China Pathology AI Software Revenue by Type (2027-2032)
  5. 10.3 China Pathology AI Software Revenue Share by Type (2021-2032)
  6. 10.4 China Pathology AI Software Revenue by Application (2021-2032)
  7. 10.4.1 China Pathology AI Software Revenue by Application (2021-2026)
  8. 10.4.2 China Pathology AI Software Revenue by Application (2027-2032)
  9. 10.5 China Pathology AI Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pathology AI Software Revenue (2021-2032)
  2. 11.2 Asia Pathology AI Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pathology AI Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pathology AI Software Revenue by Type (2027-2032)
  5. 11.3 Asia Pathology AI Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pathology AI Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pathology AI Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pathology AI Software Revenue by Application (2027-2032)
  9. 11.5 Asia Pathology AI Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pathology AI Software Revenue by Country
  11. 11.6.1 Asia Pathology AI Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pathology AI Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pathology AI Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pathology AI Software Revenue (2021-2032)
  2. 12.2 SAMEA Pathology AI Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pathology AI Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pathology AI Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pathology AI Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pathology AI Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pathology AI Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pathology AI Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pathology AI Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pathology AI Software Revenue by Country
  11. 12.6.1 SAMEA Pathology AI Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pathology AI Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pathology AI Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst